WHO CAN BENEFIT FROM THE SYSTEMIC APPROACH OF A REFLECTING TEAM

被引:0
|
作者
HOGER, C
TEMME, M
GEIKEN, G
机构
关键词
SYSTEMIC APPROACH; REFLECTING TEAM; EVALUATION STUDY;
D O I
暂无
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
In an evaluation study we investigated the effectiveness of the reflecting team approach compared to eclectic child psychaitric treatment in an outpatient setting and the indications for each type of treatment. The relationship between treatment outcome and diagnostic data obtained with the Multi-axial Classification Scheme was examined in 22 families treated with the reflecting team approach and in a second group of families matched on all important sociodemographic and diagnostic variables but receiving eclectic treatment. No difference was found between the two groups regarding symptom improvement or changes in family functioning. Regarding satisfaction with treatment, the reflecting team approach was superior to the eclectic modality. In the reflecting team group parental mental disorder and inadequate intra-familial communication (according to the new fifth axis of the Multi-axial Classification Scheme) had a negative effect on outcome.
引用
收藏
页码:16 / 22
页数:7
相关论文
共 50 条
  • [31] VGKC AUTOIMMUNITY: ARE WE MISSING PATIENTS WHO CAN BENEFIT FROM IMMUNOTHERAPY?
    Umemura, Yoshie
    Ronan, Lara
    NEURO-ONCOLOGY, 2013, 15 : 35 - 35
  • [32] Who will benefit from apomixis?
    Bicknell, RA
    Bicknell, KB
    BIOTECHNOLOGY AND DEVELOPMENT MONITOR, 1999, (37) : 17 - 21
  • [33] Who will benefit from DNase?
    Rubin, BK
    PEDIATRIC PULMONOLOGY, 1999, 27 (01) : 3 - 4
  • [34] Who Will Benefit From Metformin?
    Mortimer, Joanne E.
    Seewaldt, Victoria
    JAMA ONCOLOGY, 2022, 8 (07) : 979 - 981
  • [35] WHO WILL BENEFIT FROM GRISEOFULVIN
    KINGERY, FAJ
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1964, 190 (02): : 149 - &
  • [36] WHO WILL BENEFIT FROM GLASNOST
    GIBIAN, G
    ORBIS-A JOURNAL OF WORLD AFFAIRS, 1988, 32 (03): : 440 - 442
  • [37] Extended indication for HPV vaccination: who can benefit?
    Hampl, Monika
    Hillemanns, Peter
    Jentschke, Matthias
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2022, 82 (01) : 26 - 30
  • [38] Rituximab for idiopathic membranous nephropathy: Who can benefit?
    Ruggenenti, Piero
    Chiurchiu, Carlos
    Abbate, Mauro
    Perna, Annalisa
    Cravedi, Paolo
    Bontempelli, Mario
    Remuzzi, Giuseppe
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (04): : 738 - 748
  • [39] Resection of Recurrent Pancreatic Cancer: Who Can Benefit?
    Nienhueser, Henrik
    Buechler, Markus W.
    Schneider, Martin
    VISCERAL MEDICINE, 2021, : 42 - 48
  • [40] Lipid-lowering therapy: who can benefit?
    Lewis, Sandra J.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2011, 7 : 525 - 534